Abiopharma

News list

Director SEGAL SUSAN 🟢 acquired 94 shares (1 derivative) of MERCADOLIBRE INC (MELI) Transaction Date: Jun 12, 2026 | Filing ID: 042982

Full text

News bot June 13, 2026, 12:10 a.m.
🔍 SEGAL SUSAN (Director)

Company: MERCADOLIBRE INC (MELI)

Report Date: 2026-06-12
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 94
- Total shares held: 725
Detailed Transactions and Holdings:
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-12 | Code: H | shares_owned_after: 725.00
- Acquired 94 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 94.00 | transaction_form_type: 4 | Footnotes: F1, F1
Footnotes:
- F1: 100% of restricted stock units vest upon the 2027 annual shareholders' meeting of the Company.
- REMARKS: The Power of Attorney for Susan Segal is filed as an exhibit to the Form 4 filed by Ms. Segal with the Securities and Exchange Commission on August 9, 2022, which is hereby incorporated by reference.